These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 18071361)
1. Population attributable fractions for ovarian cancer in Swedish women by morphological type. Granström C; Sundquist J; Hemminki K Br J Cancer; 2008 Jan; 98(1):199-205. PubMed ID: 18071361 [TBL] [Abstract][Full Text] [Related]
2. Ovarian Cancer Risk Factors by Histologic Subtype: An Analysis From the Ovarian Cancer Cohort Consortium. Wentzensen N; Poole EM; Trabert B; White E; Arslan AA; Patel AV; Setiawan VW; Visvanathan K; Weiderpass E; Adami HO; Black A; Bernstein L; Brinton LA; Buring J; Butler LM; Chamosa S; Clendenen TV; Dossus L; Fortner R; Gapstur SM; Gaudet MM; Gram IT; Hartge P; Hoffman-Bolton J; Idahl A; Jones M; Kaaks R; Kirsh V; Koh WP; Lacey JV; Lee IM; Lundin E; Merritt MA; Onland-Moret NC; Peters U; Poynter JN; Rinaldi S; Robien K; Rohan T; Sandler DP; Schairer C; Schouten LJ; Sjöholm LK; Sieri S; Swerdlow A; Tjonneland A; Travis R; Trichopoulou A; van den Brandt PA; Wilkens L; Wolk A; Yang HP; Zeleniuch-Jacquotte A; Tworoger SS J Clin Oncol; 2016 Aug; 34(24):2888-98. PubMed ID: 27325851 [TBL] [Abstract][Full Text] [Related]
3. Familial invasive and borderline ovarian tumors by proband status, age and histology. Hemminki K; Granström C Int J Cancer; 2003 Jul; 105(5):701-5. PubMed ID: 12740921 [TBL] [Abstract][Full Text] [Related]
4. Low-dose aspirin use and the risk of ovarian cancer in Denmark. Baandrup L; Kjaer SK; Olsen JH; Dehlendorff C; Friis S Ann Oncol; 2015 Apr; 26(4):787-792. PubMed ID: 25538177 [TBL] [Abstract][Full Text] [Related]
5. [Endometriosis as a risk factor for ovarian cancer]. Vargas-Hernández VM Cir Cir; 2013; 81(2):163-8. PubMed ID: 23522320 [TBL] [Abstract][Full Text] [Related]
6. Incidence of epithelial ovarian cancer according to histologic subtypes in Korea, 1999 to 2012. Kim SI; Lim MC; Lim J; Won YJ; Seo SS; Kang S; Park SY J Gynecol Oncol; 2016 Jan; 27(1):e5. PubMed ID: 26463436 [TBL] [Abstract][Full Text] [Related]
7. Population attributable risks for breast cancer in Swedish women by morphological type. Granström C; Sundquist J; Hemminki K Breast Cancer Res Treat; 2008 Oct; 111(3):559-68. PubMed ID: 17990099 [TBL] [Abstract][Full Text] [Related]
8. Hormone replacement therapy and the risk of invasive epithelial ovarian cancer in Swedish women. Riman T; Dickman PW; Nilsson S; Correia N; Nordlinder H; Magnusson CM; Weiderpass E; Persson IR J Natl Cancer Inst; 2002 Apr; 94(7):497-504. PubMed ID: 11929950 [TBL] [Abstract][Full Text] [Related]
9. Borderline ovarian tumours: retrospective analysis of twenty-one cases. Saygili U; Uslu T; Erten O; Doğan E Eur J Gynaecol Oncol; 1998; 19(2):182-5. PubMed ID: 9611063 [TBL] [Abstract][Full Text] [Related]
10. Birth weight and the risk of histological subtypes of ovarian and endometrial cancers: Results from the Copenhagen School Health Records Register. Trabert B; Aarestrup J; Ulrich LG; Wentzensen N; Sørensen TIA; Baker JL Gynecol Oncol; 2018 Mar; 148(3):547-552. PubMed ID: 29331371 [TBL] [Abstract][Full Text] [Related]
11. Differences in tumor type in low-stage versus high-stage ovarian carcinomas. Köbel M; Kalloger SE; Huntsman DG; Santos JL; Swenerton KD; Seidman JD; Gilks CB; Int J Gynecol Pathol; 2010 May; 29(3):203-11. PubMed ID: 20407318 [TBL] [Abstract][Full Text] [Related]
12. Second neoplasms after invasive and borderline ovarian cancer. Levi F; Randimbison L; Blanc-Moya R; La Vecchia C Eur J Cancer Prev; 2009 Jun; 18(3):216-9. PubMed ID: 19491608 [TBL] [Abstract][Full Text] [Related]
13. Ovarian surface epithelial neoplasms in the pediatric population: incidence, histologic subtype, and natural history. Hazard FK; Longacre TA Am J Surg Pathol; 2013 Apr; 37(4):548-53. PubMed ID: 23388124 [TBL] [Abstract][Full Text] [Related]
14. Histological subtypes of ovarian cancer associated with parity and breastfeeding in the prospective Million Women Study. Gaitskell K; Green J; Pirie K; Barnes I; Hermon C; Reeves GK; Beral V; Int J Cancer; 2018 Jan; 142(2):281-289. PubMed ID: 28929490 [TBL] [Abstract][Full Text] [Related]
15. Epidemiologic features of borderline ovarian tumors in California: a population-based study. Morris CR; Liu L; Rodriguez AO; Cress RD; Snipes K Cancer Causes Control; 2013 Apr; 24(4):665-74. PubMed ID: 23314731 [TBL] [Abstract][Full Text] [Related]
16. Prevalence of endometriosis in ovarian cancer. Yoshikawa H; Jimbo H; Okada S; Matsumoto K; Onda T; Yasugi T; Taketani Y Gynecol Obstet Invest; 2000; 50 Suppl 1():11-7. PubMed ID: 11093056 [TBL] [Abstract][Full Text] [Related]
17. Risk factors for different histological types of ovarian cancer. Parazzini F; Chiaffarino F; Negri E; Surace M; Benzi G; Franceschi S; Fedele L; La Vecchia C Int J Gynecol Cancer; 2004; 14(3):431-6. PubMed ID: 15228415 [TBL] [Abstract][Full Text] [Related]
18. Morphological subtypes of ovarian carcinoma: a review with emphasis on new developments and pathogenesis. McCluggage WG Pathology; 2011 Aug; 43(5):420-32. PubMed ID: 21716157 [TBL] [Abstract][Full Text] [Related]
19. Polymorphisms in BRCA1 and BRCA2 and risk of epithelial ovarian cancer. Wenham RM; Schildkraut JM; McLean K; Calingaert B; Bentley RC; Marks J; Berchuck A Clin Cancer Res; 2003 Oct; 9(12):4396-403. PubMed ID: 14555511 [TBL] [Abstract][Full Text] [Related]
20. Risk of specific types of ovarian cancer after borderline ovarian tumors in Denmark: A nationwide study. Hannibal CG; Frederiksen K; Vang R; Kurman RJ; Kjaer SK Int J Cancer; 2020 Aug; 147(4):990-995. PubMed ID: 31930502 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]